Reviewing Cushman & Wakefield (NYSE:CWK) & Gyrodyne (NASDAQ:GYRO)

Gyrodyne (NASDAQ:GYRO) and Cushman & Wakefield (NYSE:CWK) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability.

Analyst Recommendations

This is a summary of recent ratings and target prices for Gyrodyne and Cushman & Wakefield, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gyrodyne	0	0	0	0	0.00
Cushman & Wakefield	0	5	5	0	2.50

Cushman & Wakefield has a consensus target price of $17.88, suggesting a potential upside of 8.53%. Given Cushman & Wakefield’s stronger consensus rating and higher possible upside, analysts clearly believe Cushman & Wakefield is more favorable than Gyrodyne .

Profitability

This table compares Gyrodyne and Cushman & Wakefield’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Gyrodyne	N/A	N/A	N/A
Cushman & Wakefield	2.23%	14.69%	3.60%

Earnings & Valuation

This table compares Gyrodyne and Cushman & Wakefield”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gyrodyne	N/A	N/A	N/A	N/A	N/A
Cushman & Wakefield	$10.00 billion	0.38	$131.30 million	$0.96	17.16

Cushman & Wakefield has higher revenue and earnings than Gyrodyne .

Insider and Institutional Ownership

71.4% of Gyrodyne shares are owned by institutional investors. Comparatively, 95.6% of Cushman & Wakefield shares are owned by institutional investors. 12.1% of Gyrodyne shares are owned by company insiders. Comparatively, 0.5% of Cushman & Wakefield shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk and Volatility

Gyrodyne has a beta of 0.47, suggesting that its stock price is 53% less volatile than the S&P 500. Comparatively, Cushman & Wakefield has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500.

Summary

Cushman & Wakefield beats Gyrodyne on 9 of the 10 factors compared between the two stocks.

About Gyrodyne

Gyrodyne, LLC owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. Gyrodyne owns a 63 acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property which is the subject of plans to seek value-enhancing entitlements. Gyrodyne also owns a medical office park in Cortlandt Manor, New York which is also the subject of a subdivision application. Gyrodyne's common shares are traded on the NASDAQ Stock Market under the symbol GYRO.

About Cushman & Wakefield

Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America. The EMEA segment includes operations in the UK, France, Netherlands and other markets in Europe and the Middle East. The APAC segment comprises of operations in Australia, Singapore, China and other markets in the Asia Pacific region. The company was founded in 1917 and is headquartered in London, the United Kingdom.